News
$Immuneering (IMRX.US)$ Reuters· 1 min ago
Immuneering Announces Positive Initial Phase 2a Data Including Complete and Partial Responses With Imm-1-104 in Combination With Chemotherapy in First-Line Pancreatic Cancer Patients
Immuneering Announces Positive Initial Phase 2a Data Including Complete and Partial Responses With Imm-1-104 in Combination With Chemotherapy in First-Line Pancreatic Cancer Patients
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Matt101 : been holding this one for awhile
Trytosaveabit OP Matt101 : Nice! Hope it treats you great! GL
Matt101 : thanks you think this will run into tomorrow on this news ?
Trytosaveabit OP Matt101 : Since it came after market close! I do think at least in PM! 4AM could get a boost? NFA